India assumes the Presidency of the WHA, the top decision making body of the World Health organisation (WHO) after a gap of 19 years. The 68th Session of the World Health Assembly (WHA) is heald at Geneva betwwen May 18 – May 27. Leading a high level Indian delegation to the assesmbly, Minister of Health & Family Welfare Jagat Prakash Nadda will preside over the 68th session of WHA.
On the sidelines of WHA, The Union Minister is expected to participate in a number of bilateral and multilateral meetings including the Commonwealth Health Ministers’ Meeting, 8th NAM Health Ministers’ Meeting and BRICS Health Ministers’ meeting. The official statement read, “The Assembly is expected to deliberate on key issues of global interest including anti-microbial resistance, air pollution and health, global health emergency, preparedness and surveillance, global strategy and plan of action on public health, innovation and intellectual property, and research and development in neglected tropical diseases.” Prior to the reception for health ministers , J P Nadda and Dr. Margaret Chan Director-General, WHO will jointly inaugurate a photo exhibition ‘Yoga for All, Yoga for Health’.
Other News
SEC – Special Expert Committee
The Central Drugs Standard Control Organization (CDSCO) has recently published an article titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read MoreMedical Devices with Extended CE Certification Are Now Accepted On The UK Market
The MHRA revised its guidelines to make clear its stance and reflect its intention to extend the acceptance of CE-marked medical devices on the British market beyond June 30th, 2023. A statutory document that will […]
Read More
